MedWatch

Novo Nordisk Foundation becomes bigger sponsor of state research

The Novo Nordisk Foundation is providing financial support for a larger portion of public research than it has done in the past.

Photo: Gregers Tycho/Ritzau Scanpix

Last year, the Novo Nordisk Foundation financed 13% of state research in Denmark compared to 5.8% in 2018, Danish media Finans reports.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs